Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Saved in:
Bibliographic Details
Title: Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.
Authors: Korompis M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., De Voss CJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Li S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Ateere A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., McShane H; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Stylianou E; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1807190. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1807190